NDC 72893-007

Zevalin

Ibritumomab Tiuxetan

Zevalin is a Kit in the Human Prescription Drug category. It is labeled and distributed by Acrotech Biopharma Llc. The primary component is .

• Product ID: 72893-007_bc9bcb73-d797-4696-8519-a1077b2d967b
• NDC: 72893-007
• Product Type: Human Prescription Drug
• Proprietary Name: Zevalin
• Generic Name: Ibritumomab Tiuxetan
• Dosage Form: Kit
• Marketing Start Date: 2002-02-19
• Marketing Category: BLA / BLA
• Application Number: BLA125019
• Labeler Name: Acrotech Biopharma LLC
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 72893-007-04

1 KIT in 1 CARTON (72893-007-04) * 10 mL in 1 VIAL * 2 mL in 1 VIAL * 2 mL in 1 VIAL

• Marketing Start Date: 2002-02-19
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 72893-007-04 [72893000704]

Zevalin KIT

• Marketing Category: BLA
• Application Number: BLA125019
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2002-02-19

Drug Details

OpenFDA Data

• SPL SET ID: 25d367dc-da65-44c9-a844-1bf15339c285
• Manufacturer:
  • Acrotech Biopharma LLC

NDC Crossover Matching brand name "Zevalin" or generic name "Ibritumomab Tiuxetan"

NDC	Brand Name	Generic Name
68152-103	Zevalin	ibritumomab tiuxetan
72893-007	Zevalin	ibritumomab tiuxetan